K Number
K983460
Device Name
STAR AUTOMATED MULTI-PARAMETRIC ANALYZER
Date Cleared
1998-11-12

(43 days)

Product Code
Regulation Number
864.5425
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
STA-R® Automated Multi-Parametric Analyzer is a fully automatic 311 TV Tratomated for the performance of tests on human ellinear in the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy.
Device Description
The STA-R® instrument is a fully automatic laboratory analyzer designed to perform tests which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy. Once test samples and reagents are loaded onto the instrument, sample handling, reagent delivery, analysis and reporting of test results are performed automatically, making the STA-R® instrument a true "walk-away" system. A central processing unit controls instrument functions, including management of patient results, quality control, scheduling of instrument maintenance and workload organization. The instrument utilizes Diagnostica Stago (France) reagents, and is open to adaptation of other reagents currently commercially available from third-party manufacturers. Bar-coding of test reagents, calibrators and controls facilitates their use on the system and makes reagent management simple. Manual entry of reagent information enables the utilization of non barcoded reagents. The instrument performs multiple test methodologies in random access (as selected by the user); these include clot-based tests and photometric assays at predetermined wavelengths.
More Information

Not Found

No
The description focuses on automation of standard laboratory processes and data management, with no mention of AI or ML technologies.

No
The device is an analyzer used for diagnosing coagulation abnormalities or monitoring anticoagulant therapy, not for treating them.

Yes
The "Intended Use / Indications for Use" states that the device aids "in the diagnosis of coagulation abnormalities".

No

The device description clearly states it is a "fully automatic laboratory analyzer" and describes physical components like sample handling, reagent delivery, and analysis, indicating it is a hardware device with integrated software, not a software-only device.

Yes, this device is an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The "Intended Use / Indications for Use" section explicitly states that the device is "for the performance of tests on human specimens the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy." This clearly indicates that the device is used to examine specimens from the human body to provide information for diagnostic purposes.
  • Device Description: The description further clarifies that it's a "laboratory analyzer designed to perform tests which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy." This reinforces its use in a laboratory setting for diagnostic testing.
  • Specimen Type: The intended use mentions "human specimens," which is a key characteristic of IVD devices.
  • Purpose: The purpose is to "aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy," which falls under the scope of diagnostic testing.

Therefore, based on the provided information, the STA-R® Automated Multi-Parametric Analyzer is an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

STA-R® Automated Multi-Parametric Analyzer is a fully automatic 311 TV Tratomated for the performance of tests on human ellinear in the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy.

Product codes

JPA

Device Description

The STA-R® instrument is a fully automatic laboratory analyzer designed to perform tests which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy. Once test samples and reagents are loaded onto the instrument, sample handling, reagent delivery, analysis and reporting of test results are performed automatically, making the STA-R® instrument a true "walk-away" system. A central processing unit controls instrument functions, including management of patient results, quality control, scheduling of instrument maintenance and workload organization.

The instrument utilizes Diagnostica Stago (France) reagents, and is open to adaptation of other reagents currently commercially available from third-party manufacturers. Bar-coding of test reagents, calibrators and controls facilitates their use on the system and makes reagent management simple. Manual entry of reagent information enables the utilization of non barcoded reagents.

The instrument performs multiple test methodologies in random access (as selected by the user); these include clot-based tests and photometric assays at predetermined wavelengths.

Sample-to-sample carry-over has been demonstrated to be so low as to be undetectable.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K942117

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 864.5425 Multipurpose system for in vitro coagulation studies.

(a)
Identification. A multipurpose system for in vitro coagulation studies is a device consisting of one automated or semiautomated instrument and its associated reagents and controls. The system is used to perform a series of coagulation studies and coagulation factor assays.(b)
Classification. Class II (special controls). A control intended for use with a multipurpose system for in vitro coagulation studies is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

0

K983460

NOV 1 2 1998

AMERICAN BIOPRODUCTS COMPANY Premarket 510(k) Notification STA-R® Automated Multi-Parametric Analyzer

Page 53 of 53

SAFETY AND EFFECTIVENESS SUMMARY IX.

The STA-R® instrument is a fully automatic laboratory analyzer designed to perform tests which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy. Once test samples and reagents are loaded onto the instrument, sample handling, reagent delivery, analysis and reporting of test results are performed automatically, making the STA-R® instrument a true "walk-away" system. A central processing unit controls instrument functions, including management of patient results, quality control, scheduling of instrument maintenance and workload organization.

The instrument utilizes Diagnostica Stago (France) reagents, and is open to adaptation of other reagents currently commercially available from third-party manufacturers. Bar-coding of test reagents, calibrators and controls facilitates their use on the system and makes reagent management simple. Manual entry of reagent information enables the utilization of non barcoded reagents.

The instrument performs multiple test methodologies in random access (as selected by the user); these include clot-based tests and photometric assays at predetermined wavelengths.

Sample-to-sample carry-over has been demonstrated to be so low as to be undetectable.

The STA-R® instrument is substantially equivalent to the commercially available STA® analyzer, also from the same manufacturer (Diagnostica Stago, France), that received 510(k) clearance under K942117.

1

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus, which is a symbol of medicine, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged in a circular pattern around the caduceus. The caduceus is depicted in black and white, and the text is also in black.

Food and Drug Administration 2098 Gaither Road Rockville MD 20850

NOV 1 2 1998 Andrew Loc B. Le, Ph.D. Director, Regulatory Affairs and Quality Assurance American Bioproducts Company Five Century Drive Parsippany, New Jersey 07054

Re : K983460 STA-R® Automated Multiparametric Analyzer Trade Name: Requlatory Class: II Product Code: JPA Dated: September 30, 1998 Received: September 30, 1998

Dear Dr. Le:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Druq, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions aqainst misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Druq Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obliqation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.

2

Paqe 2

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Steven Butman

Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

Page 1 of 1

Attachment A

510(k) Number (if known):_K983460

Device Name: STA-R® Automated Multi-Parametric Analyzer

Indications for Use:

STA-R® Automated Multi-Parametric Analyzer is a fully automatic 311 TV Tratomated for the performance of tests on human ellinear in the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

(Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Clinical Laboratory Devices
510(k) NumberK983460
Prescription UseOROver-The-Counter Use_
(Per 21 CFR 801.109)(Optional Format 1-2-96)